1. Second line therapy for metastatic urothelial carcinoma. Clinical case of vinflunine use
   A. A. Gritskevich et al, 2022, Meditsinskiy sovet = Medical Council CrossRef
2. Current Management of Localized Muscle-Invasive Bladder Cancer: A Consensus Guideline from the Genitourinary Medical Oncologists of Canada
   Di Maria Jiang et al, 2020, Bladder Cancer CrossRef
3. Blasenkarzinomsystemtherapie
   M. Haas et al, 2021, Der Urologe CrossRef
4. Advances in diagnosis and treatment of bladder cancer
   Antonio Lopez-Beltran et al, 2024, BMJ CrossRef
5. Treatment Approaches for Cisplatin-Ineligible Patients with Invasive Bladder Cancer
   David J. Einstein et al, 2019, Current Treatment Options in Oncology CrossRef
6. Treatment of metastatic bladder cancer: current and historical aspects
   A. A. Rumyantsev, 2022, Meditsinskiy sovet = Medical Council CrossRef
7. Assessing the prevalence and severity of cisplatin-induced nephrotoxicity in a minority- low socioeconomic population in the Bronx, New York
   M Bakri Hammami et al, 2024, Journal of Chemotherapy CrossRef
8. Renal Toxicity Associated with Weekly Cisplatin and Gemcitabine Combination Therapy for Treatment of Advanced Biliary Tract Cancer
   Satoshi Kobayashi et al, 2014, Oncology CrossRef
9. Systemic Treatment-Decision Algorithms in Muscle-Invasive Bladder Cancer: Clinical Complexities and Navigating for Improved Outcomes
   Megan Giles et al, 2023, Research and Reports in Urology CrossRef
10. Aplicação intratumoral de cisplatina no tratamento de sarcóide periocular em equino
    RODRIGO RIBEIRO et al, 2022, Revista Colombiana de Ciencia Animal - RECIA CrossRef